Home Business Stocks and Gold Set Record Highs (On ‘Bad News’)

Stocks and Gold Set Record Highs (On ‘Bad News’)

Share
stocks-and-gold-set-record-highs-(on-‘bad-news’)
Stocks and Gold Set Record Highs (On ‘Bad News’)
Share

Bad economic news seems to be good for stocks, since the more bad news we see, the more likely the Fed is to cut key rates.

Stocks and Gold Set Record Highs (On ‘Bad News’)

Three 1kg gold bullion bars lay on the counter in a gold dealers in Birmingham’s jewelery quarter in Birmingham, England, on Dec. 13, 2023. Christopher Furlong/Getty Images

Louis Navellier

|Updated:

Commentary

Last Friday, several events helped push stocks (and gold) to all-time highs, but mostly because bad news is good for stocks (and gold), since bad economic news tends to make a key interest rate cut more likely.

Louis Navellier

Louis Navellier is chairman and founder of Navellier & Associates in Reno, Nevada, which manages approximately $1 billion in assets. One of Wall Street’s renowned growth investors, Navellier writes five investment newsletters focused on growth investing. In addition to appearing on Bloomberg, Fox News, and CNBC giving his market outlook and analysis, he has been featured in Barron’s, Forbes, Fortune, Investor’s Business Daily, Money, Smart Money, and The Wall Street Journal.

twitter

Author’s Selected Articles

Share
Related Articles
usda-unveils-new-support-for-ranchers-to-rebuild-cattle-herds
BusinessEconomyUSUS News

USDA Unveils New Support for Ranchers to Rebuild Cattle Herds

The U.S. Department of Agriculture has unveiled a new package of measures...

how-major-us-stock-indexes-fared-aug.-31
BrightBusinessInvestingMarketsPersonal FinanceStocks

How Major US Stock Indexes Fared Aug. 31

Oil prices rose and U.S. stocks fell after American forces struck Iranian...

trump-unveils-new-drug-pricing-deals-with-9-pharmaceutical-companies
BusinessCompaniesExecutive BranchUSUS NewsUS Politics

Trump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies

President Donald Trump on Aug. 31 announced agreements with nine midsize pharmaceutical...